Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome
Motoko Unoki, … , Claire Francastel, Hiroyuki Sasaki
Motoko Unoki, … , Claire Francastel, Hiroyuki Sasaki
Published October 11, 2018
Citation Information: J Clin Invest. 2019;129(1):78-92. https://doi.org/10.1172/JCI99751.
View: Text | PDF
Research Article Cell biology Genetics

CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome

  • Text
  • PDF
Abstract

Mutations in CDCA7 and HELLS that respectively encode a CXXC-type zinc finger protein and an SNF2 family chromatin remodeler cause immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome types 3 and 4. Here, we demonstrate that the classical nonhomologous end joining (C-NHEJ) proteins Ku80 and Ku70, as well as HELLS, coimmunoprecipitated with CDCA7. The coimmunoprecipitation of the repair proteins was sensitive to nuclease treatment and an ICF3 mutation in CDCA7 that impairs its chromatin binding. The functional importance of these interactions was strongly suggested by the compromised C-NHEJ activity and significant delay in Ku80 accumulation at DNA damage sites in CDCA7- and HELLS-deficient HEK293 cells. Consistent with the repair defect, these cells displayed increased apoptosis, abnormal chromosome segregation, aneuploidy, centrosome amplification, and significant accumulation of γH2AX signals. Although less prominent, cells with mutations in the other ICF genes DNMT3B and ZBTB24 (responsible for ICF types 1 and 2, respectively) showed similar defects. Importantly, lymphoblastoid cells from ICF patients shared the same changes detected in the mutant HEK293 cells to varying degrees. Although the C-NHEJ defect alone did not cause CG hypomethylation, CDCA7 and HELLS are involved in maintaining CG methylation at centromeric and pericentromeric repeats. The defect in C-NHEJ may account for some common features of ICF cells, including centromeric instability, abnormal chromosome segregation, and apoptosis.

Authors

Motoko Unoki, Hironori Funabiki, Guillaume Velasco, Claire Francastel, Hiroyuki Sasaki

×

Figure 3

ICF mutant cells display proliferation defects, aneuploidy, and apoptosis.

Options: View larger image (or click on image) Download as PowerPoint
ICF mutant cells display proliferation defects, aneuploidy, and apoptosi...
(A) Proliferation curves of WT and mutant cells. Since 2 mutant clones per each gene showed similar results, a curve obtained from only 1 clone is shown. Fifty thousand cells were seeded, cultured, and counted at indicated time points (mean ± SEM, n = 4 for each clone). The average doubling time is shown on the right. (B) Cell cycle analysis based on DNA content measured by flow cytometry. Experiments were performed in biological triplicate and technical triplicate (n = 9). Because HEK293 cells are hypotriploid (38), those in G1 phase are just below 3n, and those in G2/M phase are near 6n. *P < 0.0011 and **P < 0.0002 (Mann-Whitney U test) were considered statistically significant at the 5% and 1% levels, respectively, after Bonferroni correction. The exact P values, which were significant (P < 0.01) before the correction, are shown for reference. (C) Representative images from biological duplicate showing apoptotic cells. DNA fragmentation was analyzed by TUNEL assay (green), and nuclei were counterstained with DAPI. Scale bars: 20 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts